Comparison of short‑term outcomes and 3-year overall survival between robotic and laparoscopic gastrectomy for gastric cancer: a propensity score matching analysis.
코호트
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
675 patients undergoing minimally invasive gastrectomy were recruited from January 2016 to January 2018 (LG: = 567; RG: = 108).
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Our findings suggest that RG may offer advantages in terms of blood loss, surgical complications, recovery time, and pain management compared to LG while maintaining similar overall survival rates.
[BACKGROUND] Despite the increasing use of robotic gastrectomy (RG) as an alternative to laparoscopic gastrectomy (LG) in treating gastric cancer, controversy remains over the advantages of RG compare
- 연구 설계 cohort study
APA
Zhang L, Cui J, et al. (2024). Comparison of short‑term outcomes and 3-year overall survival between robotic and laparoscopic gastrectomy for gastric cancer: a propensity score matching analysis.. Acta chirurgica Belgica, 124(6), 478-486. https://doi.org/10.1080/00015458.2024.2348256
MLA
Zhang L, et al.. "Comparison of short‑term outcomes and 3-year overall survival between robotic and laparoscopic gastrectomy for gastric cancer: a propensity score matching analysis.." Acta chirurgica Belgica, vol. 124, no. 6, 2024, pp. 478-486.
PMID
38693890 ↗
Abstract 한글 요약
[BACKGROUND] Despite the increasing use of robotic gastrectomy (RG) as an alternative to laparoscopic gastrectomy (LG) in treating gastric cancer, controversy remains over the advantages of RG compared to LG and there is a paucity of studies comparing the two techniques regarding patient survival.
[METHODS] In this retrospective cohort study, 675 patients undergoing minimally invasive gastrectomy were recruited from January 2016 to January 2018 (LG: = 567; RG: = 108). A one-to-one propensity score matching (PSM) analysis was applied to minimize the selection bias due to confounding factors, yielding 104 patients in each of the RG and LG groups. After matching, the short-term outcomes and 3-year overall survival were compared in the two groups.
[RESULTS] The PSM cohort analysis showed a similar 3-year overall survival between RG and LG groups ( = .249). Concerning the short-term outcomes, the RG compared to LG resulted in lower blood loss ( = .01), lower postoperative complications ( = .001), lower postoperative pain ( = .016), earlier initiation of soft diet ( = .011), shorter hospital stay ( = .012), but higher hospitalization expenses ( = .001).
[CONCLUSION] Our findings suggest that RG may offer advantages in terms of blood loss, surgical complications, recovery time, and pain management compared to LG while maintaining similar overall survival rates. However, RG is associated with higher hospital costs, potentially limiting its wider adoption. Further research, including large, multi-center randomized controlled trials with longer patient follow-up, particularly for advanced gastric cancer, is needed to confirm these findings.
[METHODS] In this retrospective cohort study, 675 patients undergoing minimally invasive gastrectomy were recruited from January 2016 to January 2018 (LG: = 567; RG: = 108). A one-to-one propensity score matching (PSM) analysis was applied to minimize the selection bias due to confounding factors, yielding 104 patients in each of the RG and LG groups. After matching, the short-term outcomes and 3-year overall survival were compared in the two groups.
[RESULTS] The PSM cohort analysis showed a similar 3-year overall survival between RG and LG groups ( = .249). Concerning the short-term outcomes, the RG compared to LG resulted in lower blood loss ( = .01), lower postoperative complications ( = .001), lower postoperative pain ( = .016), earlier initiation of soft diet ( = .011), shorter hospital stay ( = .012), but higher hospitalization expenses ( = .001).
[CONCLUSION] Our findings suggest that RG may offer advantages in terms of blood loss, surgical complications, recovery time, and pain management compared to LG while maintaining similar overall survival rates. However, RG is associated with higher hospital costs, potentially limiting its wider adoption. Further research, including large, multi-center randomized controlled trials with longer patient follow-up, particularly for advanced gastric cancer, is needed to confirm these findings.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- Stomach Neoplasms
- Gastrectomy
- Propensity Score
- Male
- Laparoscopy
- Robotic Surgical Procedures
- Female
- Retrospective Studies
- Middle Aged
- Treatment Outcome
- Aged
- Survival Rate
- Length of Stay
- Time Factors
- Postoperative Complications
- Robotic gastrectomy
- gastric cancer
- laparoscopic gastrectomy
- propensity score matching
같은 제1저자의 인용 많은 논문 (5)
- Rapid and sensitive detection of botulinum toxin type A in complex sample matrices by AlphaLISA.
- A new technique for Asian nasal tip shaping: "twin tower" folding ear cartilage transplantation.
- ELK1/NOL3/GRP78 axis regulates proliferation and stemness in TP53-mutant colon cancer by enhancing adaptive endoplasmic reticulum stress.
- Clinical Characteristics and Prognostic Prediction of Secondary Solid Malignancies in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma.
- Mitochondrial transfer in the HSC-HCC-macrophage network shapes hepatocellular carcinoma progression.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.